Gavi terminates COVID vaccine deal with Clover, demands $224M repayment
24th March 2025 Uncategorised 0International vaccine partnership Gavi has discontinued a COVID vaccine advance purchase agreement with Clover Biopharmaceuticals of China and is asking for repayment of $224 million.
More: Gavi terminates COVID vaccine deal with Clover, demands 4M repayment
Source: fierce